IBD is characterized by chronic inflammation of the gastrointestinal tract, with pro-inflammatory biomarkers such as C-reactive protein (CRP), fecal calprotectin, and TNF-α elevated during the preclinical and clinical stages [1, 45, 46]. The gene discussed is TNF; the disease is inflammatory bowel disease.